<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02132676</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 15-321</org_study_id>
    <nct_id>NCT02132676</nct_id>
  </id_info>
  <brief_title>Shared Health Appointments and Reciprocal Enhanced Support</brief_title>
  <acronym>SHARES</acronym>
  <official_title>Peer Support to Enhance Diabetes Shared Medical Appointments: Examining Comparative Effectiveness in VA Health Systems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of a peer-to-peer program (P2P) in&#xD;
      addition to Shared Medical Appointments (SMAs) compared to SMAs alone for the treatment of&#xD;
      diabetes in five VA health systems, and to study the implementation process in order to&#xD;
      gather information required to disseminate the program more broadly in the VHA system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Providers are often unable to communicate as frequently as needed with diabetes patients who&#xD;
      have poor risk factor control and face significant self-management challenges. Moreover, many&#xD;
      VA patients face barriers to attending frequent face-to-face visits. This project will&#xD;
      evaluate the implementation of a novel program found in a recent VA randomized, controlled&#xD;
      trial to significantly improve VA patients' diabetes-specific social support, insulin starts,&#xD;
      and glycemic control compared to usual nurse care management. The program uses periodic group&#xD;
      sessions in conjunction with calls between paired patients with diabetes to promote more&#xD;
      effective care management as well as peer-to-peer (P2P) communication among diabetes patients&#xD;
      who both have poor glycemic control and are working on similar care goals. &quot;Peer buddies&quot; are&#xD;
      encouraged to talk by phone at least weekly to provide mutual support and share their&#xD;
      progress on meeting their self-management goals. The goal of this service is to enhance the&#xD;
      effect of shared medical appointments (SMAs), a service model demonstrated to be effective in&#xD;
      improving outcomes among patients with diabetes and other chronic conditions and now being&#xD;
      widely implemented in VA. Based on the success of the efficacy trial of this intervention,&#xD;
      the investigators now seek to evaluate a wider-scale implementation of this program. During&#xD;
      implementation of the P2P program in conjunction with shared medical appointments (SMAs) in&#xD;
      five diverse VA facilities, the investigators will evaluate the effectiveness of SMAs alone&#xD;
      and SMAs+P2P compared to usual care, and study the implementation process in order to gather&#xD;
      information required to disseminate the program more broadly in Veterans Health&#xD;
      Administration (VHA).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 25, 2016</start_date>
  <completion_date type="Actual">July 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 28, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Glycemic Control</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Glycemic control (measured by Hemoglobin A1c) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values of A1c, the investigators will also examine the change in the percentage of patients with an average A1c &gt; 8%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Systolic Blood Pressure (SBP)</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Systolic blood pressure (SBP) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values, the investigators will also examine the change in percentage of patients with an average SBP &gt; 140.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin Starts</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>The number of participants who are not on insulin at baseline and are started on insulin during the 6 and 12-month post-enrollment periods will be totaled and compared for the SMA group and the no intervention control group. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency Department (ED) Visits</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Statin Starts</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>The number of participants who are not on a statin at baseline and are started on insulin during the 6 and 12-month post-enrollment periods will be totaled and compared for the SMA group and the no intervention control group. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Number of Classes of Anti-hypertensive Meds</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Change in antihypertensive use (number of classes of prescribed anti-hypertensives) in each group will be assessed at baseline and following the 6 and 12-month post-enrollment evaluation periods. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient-reported Satisfaction With VA Care</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Patients' satisfaction with VA care will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: VA Healthcare Satisfaction Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient-reported Diabetes Distress</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Patients' level of diabetes distress will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Diabetes Distress Scale Scale ranges: 1-5 (Not a Problem=1, Minor Problem=2, Moderate Problem=3, Somewhat Serious Problem=4, Serious Problem=5) Direction of range: Lower score indicates a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient-reported Degree of Diabetes Support</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Patients' degree of diabetes support will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Diabetes Support Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient-reported Degree of Self-Efficacy</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Patients' degree of self-efficacy will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Williams Self-Efficacy Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalizations</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospitalizations</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PCP Visits</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nurse Case Manager Visits</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endocrinology Visits</measure>
    <time_frame>6 months and 12 months post-enrollment</time_frame>
    <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1536</enrollment>
  <condition>Diabetes Insipidus</condition>
  <arm_group>
    <arm_group_label>Active treatment</arm_group_label>
    <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether the Peer to Peer (P2P) program was offered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <description>The randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        VA outpatients with uncontrolled diabetes receiving care at a participating VA Medical&#xD;
        Center during implementation of a P2P program for diabetes management in conjunction with&#xD;
        SMAs&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Veterans enrolled into diabetes Shared Medical Appointments (SMAs) at participating sites,&#xD;
        and a random subset of those meeting criteria for diabetes SMAs who have not yet&#xD;
        participated:&#xD;
&#xD;
          -  Veteran receiving care at a participating VA Medical Center&#xD;
&#xD;
          -  Meets at least one of the following criteria in the past 2 years;&#xD;
&#xD;
               -  at least 1 VA hospitalization with a diabetes-related International&#xD;
                  Classification Of Diseases-9 (ICD-9) code,&#xD;
&#xD;
               -  at least 2 VA outpatient visits with a diabetes-related ICD-9 code, or&#xD;
&#xD;
               -  At least 1 VA prescription for a glucose control medication (insulin or oral&#xD;
                  agent) or monitoring supplies&#xD;
&#xD;
          -  Poor glycemic control, indicated by a HbA1c in the past 6 months or:&#xD;
&#xD;
               -  at least 7.5% if age &lt;70, or&#xD;
&#xD;
               -  at least 8% if age 70+&#xD;
&#xD;
          -  Has a current address and telephone number listed in VA databases&#xD;
&#xD;
          -  Is competent to provide informed consent&#xD;
&#xD;
          -  Can communicate in English and by telephone&#xD;
&#xD;
          -  Able to participate in an outpatient program&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        For no intervention control group:&#xD;
&#xD;
          -  Active substance abuse disorder (smoking cigarettes is not an exclusion)&#xD;
&#xD;
          -  Serious psychiatric illness (bipolar disorder, dementia, schizophrenia, or personality&#xD;
             disorders)&#xD;
&#xD;
          -  Terminally ill&#xD;
&#xD;
          -  Prisoner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary Ellen M Heisler, MD MPA</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Ann Arbor Healthcare System, Ann Arbor, MI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System, Palo Alto, CA</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Northern California Health Care System, Mather, CA</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Connecticut Healthcare System West Haven Campus, West Haven, CT</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Ann Arbor Healthcare System, Ann Arbor, MI</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence VA Medical Center, Providence, RI</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Heisler M, Burgess J, Cass J, Chardos JF, Guirguis AB, Jeffery SM, Strohecker LA, Tremblay AS, Wu WC, Zulman DM. The Shared Health Appointments and Reciprocal Enhanced Support (SHARES) study: study protocol for a randomized trial. Trials. 2017 May 26;18(1):239. doi: 10.1186/s13063-017-1959-7.</citation>
    <PMID>28549471</PMID>
  </reference>
  <reference>
    <citation>Kowalski CP, Veeser M, Heisler M. Formative evaluation and adaptation of pre-and early implementation of diabetes shared medical appointments to maximize sustainability and adoption. BMC Fam Pract. 2018 Jul 7;19(1):109. doi: 10.1186/s12875-018-0797-3.</citation>
    <PMID>29981568</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 21, 2013</study_first_submitted>
  <study_first_submitted_qc>May 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2014</study_first_posted>
  <results_first_submitted>June 30, 2020</results_first_submitted>
  <results_first_submitted_qc>August 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 19, 2020</results_first_posted>
  <last_update_submitted>August 19, 2020</last_update_submitted>
  <last_update_submitted_qc>August 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Self-Management</keyword>
  <keyword>Patient Care Management</keyword>
  <keyword>Peer Group</keyword>
  <keyword>Disease Management</keyword>
  <keyword>Health Plan Implementation</keyword>
  <keyword>Diabetes Mellitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Insipidus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 19, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT02132676/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Usual Care</title>
          <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
        </group>
        <group group_id="P2">
          <title>Active Treatment</title>
          <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="727"/>
                <participants group_id="P2" count="809"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="727"/>
                <participants group_id="P2" count="809"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Usual Care</title>
          <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
        </group>
        <group group_id="B2">
          <title>Active Treatment</title>
          <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="727"/>
            <count group_id="B2" value="809"/>
            <count group_id="B3" value="1536"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.8" spread="12.7"/>
                    <measurement group_id="B2" value="67.1" spread="9.2"/>
                    <measurement group_id="B3" value="67.5" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="707"/>
                    <measurement group_id="B2" value="782"/>
                    <measurement group_id="B3" value="1489"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="85"/>
                    <measurement group_id="B2" value="148"/>
                    <measurement group_id="B3" value="233"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="536"/>
                    <measurement group_id="B2" value="545"/>
                    <measurement group_id="B3" value="1081"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>A1c</title>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.9" spread="1.3"/>
                    <measurement group_id="B2" value="9.1" spread="1.5"/>
                    <measurement group_id="B3" value="9.0" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>SBP</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="137.7" spread="15.2"/>
                    <measurement group_id="B2" value="136.2" spread="13.4"/>
                    <measurement group_id="B3" value="136.8" spread="14.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>On insulin</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="255"/>
                    <measurement group_id="B2" value="385"/>
                    <measurement group_id="B3" value="640"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>On statin</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="470"/>
                    <measurement group_id="B2" value="603"/>
                    <measurement group_id="B3" value="1073"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Classes of anti-hypertensive meds</title>
          <units>number of classes of antihypertensives</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.2" spread="1.3"/>
                    <measurement group_id="B2" value="2.4" spread="1.2"/>
                    <measurement group_id="B3" value="2.3" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Primary Care Physician (PCP) in-person visits in past 8 months</title>
          <units>number of in-person PCP visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.2" spread="3.4"/>
                    <measurement group_id="B2" value="3.4" spread="3.1"/>
                    <measurement group_id="B3" value="3.3" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PCP phone visits in past 8 months</title>
          <units>number of PCP phone visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.7" spread="1.5"/>
                    <measurement group_id="B2" value="0.7" spread="1.2"/>
                    <measurement group_id="B3" value="0.7" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nurse case manager in-person visits in past 8 months</title>
          <units>number of RNCM in-person visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.2" spread="0.8"/>
                    <measurement group_id="B2" value="0.2" spread="0.7"/>
                    <measurement group_id="B3" value="0.2" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nurse case manager phone visits in past 8 months</title>
          <units>number of RNCM phone visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.3" spread="0.9"/>
                    <measurement group_id="B2" value="0.3" spread="0.9"/>
                    <measurement group_id="B3" value="0.3" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Endocrinology in-person visits in past 8 months</title>
          <units>number of Endocrinology in-person visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.2" spread="0.8"/>
                    <measurement group_id="B2" value="0.3" spread="0.8"/>
                    <measurement group_id="B3" value="0.3" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Glycemic Control</title>
        <description>Glycemic control (measured by Hemoglobin A1c) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values of A1c, the investigators will also examine the change in the percentage of patients with an average A1c &gt; 8%.</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those with A1c values documented in the electronic health record (EHR) during the evaluation windows were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Glycemic Control</title>
          <description>Glycemic control (measured by Hemoglobin A1c) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values of A1c, the investigators will also examine the change in the percentage of patients with an average A1c &gt; 8%.</description>
          <population>Only those with A1c values documented in the electronic health record (EHR) during the evaluation windows were included in the number analyzed</population>
          <units>% glycolated hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="727"/>
                    <count group_id="O2" value="809"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.92" spread="1.31"/>
                    <measurement group_id="O2" value="9.12" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="457"/>
                    <count group_id="O2" value="663"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.26" spread="1.47"/>
                    <measurement group_id="O2" value="8.16" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="427"/>
                    <count group_id="O2" value="614"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.15" spread="1.50"/>
                    <measurement group_id="O2" value="8.15" spread="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Systolic Blood Pressure (SBP)</title>
        <description>Systolic blood pressure (SBP) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values, the investigators will also examine the change in percentage of patients with an average SBP &gt; 140.</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those with SBP values documented in the EHR during the evaluation windows were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Systolic Blood Pressure (SBP)</title>
          <description>Systolic blood pressure (SBP) in each group will be assessed by the comparison of an average of the values obtained during routine outpatient clinical practice in 6-month windows preceding baseline and following the 6 and 12-month post-enrollment evaluation periods. In addition to measuring absolute values, the investigators will also examine the change in percentage of patients with an average SBP &gt; 140.</description>
          <population>Only those with SBP values documented in the EHR during the evaluation windows were included in the number analyzed</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="534"/>
                    <count group_id="O2" value="752"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.6" spread="18.9"/>
                    <measurement group_id="O2" value="137.2" spread="17.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Moths</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="555"/>
                    <count group_id="O2" value="721"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.6" spread="20.5"/>
                    <measurement group_id="O2" value="136.2" spread="18.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="536"/>
                    <count group_id="O2" value="710"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139.3" spread="19.7"/>
                    <measurement group_id="O2" value="137.4" spread="19.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Insulin Starts</title>
        <description>The number of participants who are not on insulin at baseline and are started on insulin during the 6 and 12-month post-enrollment periods will be totaled and compared for the SMA group and the no intervention control group. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Insulin Starts</title>
          <description>The number of participants who are not on insulin at baseline and are started on insulin during the 6 and 12-month post-enrollment periods will be totaled and compared for the SMA group and the no intervention control group. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="255"/>
                    <measurement group_id="O2" value="385"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="247"/>
                    <measurement group_id="O2" value="418"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="246"/>
                    <measurement group_id="O2" value="406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Emergency Department (ED) Visits</title>
        <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Emergency Department (ED) Visits</title>
          <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
          <units>number of ED visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="1.24"/>
                    <measurement group_id="O2" value="0.54" spread="1.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread="1.04"/>
                    <measurement group_id="O2" value="0.68" spread="1.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.50" spread="1.26"/>
                    <measurement group_id="O2" value="0.60" spread="1.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Statin Starts</title>
        <description>The number of participants who are not on a statin at baseline and are started on insulin during the 6 and 12-month post-enrollment periods will be totaled and compared for the SMA group and the no intervention control group. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Statin Starts</title>
          <description>The number of participants who are not on a statin at baseline and are started on insulin during the 6 and 12-month post-enrollment periods will be totaled and compared for the SMA group and the no intervention control group. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="470"/>
                    <measurement group_id="O2" value="603"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="456"/>
                    <measurement group_id="O2" value="617"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="446"/>
                    <measurement group_id="O2" value="608"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Number of Classes of Anti-hypertensive Meds</title>
        <description>Change in antihypertensive use (number of classes of prescribed anti-hypertensives) in each group will be assessed at baseline and following the 6 and 12-month post-enrollment evaluation periods. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those participants who were on at least one anti-hypertensive med during the evaluation windows were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Number of Classes of Anti-hypertensive Meds</title>
          <description>Change in antihypertensive use (number of classes of prescribed anti-hypertensives) in each group will be assessed at baseline and following the 6 and 12-month post-enrollment evaluation periods. For the no intervention control group, baseline will be the date they are identified by the data manager. For the SMA group, baseline will be the date of the first SMA.</description>
          <population>Only those participants who were on at least one anti-hypertensive med during the evaluation windows were included in the number analyzed</population>
          <units>Number of classes of anti-hypertensives</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="548"/>
                    <count group_id="O2" value="655"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.23" spread="1.27"/>
                    <measurement group_id="O2" value="2.38" spread="1.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="517"/>
                    <count group_id="O2" value="668"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.31" spread="1.28"/>
                    <measurement group_id="O2" value="2.38" spread="1.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="513"/>
                    <count group_id="O2" value="660"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.28" spread="1.19"/>
                    <measurement group_id="O2" value="2.39" spread="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Patient-reported Satisfaction With VA Care</title>
        <description>Patients' satisfaction with VA care will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: VA Healthcare Satisfaction Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Patient-reported Satisfaction With VA Care</title>
          <description>Patients' satisfaction with VA care will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: VA Healthcare Satisfaction Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
          <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="448"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="448"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.58" spread="1.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="365"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.97" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="345"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.88" spread="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Patient-reported Diabetes Distress</title>
        <description>Patients' level of diabetes distress will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Diabetes Distress Scale Scale ranges: 1-5 (Not a Problem=1, Minor Problem=2, Moderate Problem=3, Somewhat Serious Problem=4, Serious Problem=5) Direction of range: Lower score indicates a better outcome</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Patient-reported Diabetes Distress</title>
          <description>Patients' level of diabetes distress will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Diabetes Distress Scale Scale ranges: 1-5 (Not a Problem=1, Minor Problem=2, Moderate Problem=3, Somewhat Serious Problem=4, Serious Problem=5) Direction of range: Lower score indicates a better outcome</description>
          <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="451"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="451"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.43" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="350"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.19" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="315"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.03" spread="0.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Patient-reported Degree of Diabetes Support</title>
        <description>Patients' degree of diabetes support will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Diabetes Support Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Patient-reported Degree of Diabetes Support</title>
          <description>Patients' degree of diabetes support will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Diabetes Support Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
          <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="446"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="446"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.77" spread="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="351"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.29" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="314"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.09" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Patient-reported Degree of Self-Efficacy</title>
        <description>Patients' degree of self-efficacy will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Williams Self-Efficacy Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Patient-reported Degree of Self-Efficacy</title>
          <description>Patients' degree of self-efficacy will be assessed through surveys at baseline and 6 and 12 months post-enrollment for the SMA group. The following relates to the scale used:&#xD;
Scale name: Williams Self-Efficacy Scale Scale ranges: 1-6 (Strongly Disagree=1, Disagree=2, Slightly Disagree=3, Slightly Agree=4, Agree=5, Strongly Agree=6) Direction of range: Higher score indicates a better outcome</description>
          <population>Only those who completed each timepoint's survey and responded to the relevant scale items were included in the number analyzed</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="449"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="449"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.51" spread="1.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="350"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.84" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="312"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.87" spread="1.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalizations</title>
        <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalizations</title>
          <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
          <units>number of hospitalizations</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.46"/>
                    <measurement group_id="O2" value="0.10" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.52"/>
                    <measurement group_id="O2" value="0.15" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.55"/>
                    <measurement group_id="O2" value="0.12" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospitalizations</title>
        <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <population>Only those participants who had at least one hospitalization during the evaluation windows were included in the number analyzed</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospitalizations</title>
          <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
          <population>Only those participants who had at least one hospitalization during the evaluation windows were included in the number analyzed</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="810"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="61"/>
                    <count group_id="O2" value="71"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="12.7"/>
                    <measurement group_id="O2" value="3.1" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="56"/>
                    <count group_id="O2" value="84"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7" spread="33.2"/>
                    <measurement group_id="O2" value="6.3" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="63"/>
                    <count group_id="O2" value="64"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3" spread="9.2"/>
                    <measurement group_id="O2" value="8.6" spread="21.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>PCP Visits</title>
        <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>PCP Visits</title>
          <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
          <units>number of PCP visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.65" spread="1.47"/>
                    <measurement group_id="O2" value="1.57" spread="1.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.04" spread="1.20"/>
                    <measurement group_id="O2" value="1.42" spread="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.11" spread="1.19"/>
                    <measurement group_id="O2" value="1.38" spread="1.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nurse Case Manager Visits</title>
        <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Nurse Case Manager Visits</title>
          <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
          <units>number of RNCM visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="1.12"/>
                    <measurement group_id="O2" value="0.42" spread="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.38"/>
                    <measurement group_id="O2" value="0.29" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.74"/>
                    <measurement group_id="O2" value="0.23" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Endocrinology Visits</title>
        <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
        <time_frame>6 months and 12 months post-enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
          </group>
          <group group_id="O2">
            <title>Active Treatment</title>
            <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
          </group>
        </group_list>
        <measure>
          <title>Endocrinology Visits</title>
          <description>Major utilization events (admissions, bed days of care, and outpatient visits) will be collected from electronic medical records. Outpatient visits will be limited to those clinics most likely to be impacted by the intervention (e.g., primary care visits, diabetes specialty visits, and nurse visits).</description>
          <units>number of Endocrinology visits</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="727"/>
                <count group_id="O2" value="809"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.69"/>
                    <measurement group_id="O2" value="0.21" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.68"/>
                    <measurement group_id="O2" value="0.20" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-Months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.62"/>
                    <measurement group_id="O2" value="0.21" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>For each enrolled patient, adverse event data were collected from enrollment through 1 year 3 months post-enrollment.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Usual Care</title>
          <description>Randomly selected sample of those not offered participation in a Shared Medical Appointment (SMA)</description>
        </group>
        <group group_id="E2">
          <title>Active Treatment</title>
          <description>All those scheduled for a Shared Medical Appointment (SMA), regardless of whether an SMA was actually attended</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="727"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="809"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="727"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="809"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="727"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="809"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Our study sites were VAs.&#xD;
We did not collect survey data from the usual care group, so were unable to compare responses between the two arms.&#xD;
All clinical outcomes were gathered from EHR data gathered through clinical visits.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Michele Heisler</name_or_title>
      <organization>VA Ann Arbor Healthcare System Center for Clinical Management &amp; Research</organization>
      <phone>734-845-3502</phone>
      <email>mheisler@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

